%0 Generic
%T Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study
%A SCHULTZE-SEEMANN, WOLFGANG
%A SCHULZ, HOLGER
%A TSCHECHNE, BARBARA
%A HÄCKL, MANUEL
%I Anticancer Research USA Inc.
%@ 0250-7005
%@ 1791-7530
%K Cancer Research
%K Oncology
%K General Medicine
%D 2019
%C Anticancer Research USA Inc.
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation